APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lesinurad

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Lesinurad Market Outlook and Growth Opportunities 2026

1 February 2026195 pages

Choose your research edition.

Industry ResearchLesinurad Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Lesinurad Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Lesinurad Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lesinurad Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Lesinurad Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Lesinurad market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Lesinurad is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lesinurad is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lesinurad is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Lesinurad market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Lesinurad market include Ausun Pharmaceutical, Cayman Chemical, CHEMO, Clearsynth, Manus Aktteva Biopharma LLP, MSN Labs, Nifty Labs, Target Mol and UQUIFA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Lesinurad market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lesinurad and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lesinurad sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lesinurad market size, projected growth trends, production technologies, key applications, and end-use industries.

Lesinurad Segment by Company

Ausun Pharmaceutical

Cayman Chemical

CHEMO

Clearsynth

Manus Aktteva Biopharma LLP

MSN Labs

Nifty Labs

Target Mol

UQUIFA

Meso Chem

Vcare Pharmatech

Lesinurad Segment by Type

Purity ≥ 98 %

Purity ≥ 99 %

Lesinurad Segment by Application

Research Institute

Pharmaceutical

Others

Lesinurad Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Lesinurad status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Lesinurad market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Lesinurad significant trends, drivers, influence factors in global and regions.

6. To analyze Lesinurad competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lesinurad market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lesinurad and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lesinurad.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lesinurad market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lesinurad industry.

Chapter 3: Detailed analysis of Lesinurad manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Lesinurad in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Lesinurad in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Lesinurad Industry Trends Table 2. Lesinurad Industry Drivers Table 3. Lesinurad Industry Opportunities and Challenges Table 4. Lesinurad Industry Restraints Table 5. Global Lesinurad Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Lesinurad Revenue Share by Company (2021-2026) Table 7. Global Lesinurad Sales Volume by Company (t) & (2021-2026) Table 8. Global Lesinurad Sales Volume Share by Company (2021-2026) Table 9. Global Lesinurad Average Price (USD/t) of Company (2021-2026) Table 10. Global Lesinurad Company Ranking, (2024-2026) & (USD Million) Table 11. Global Lesinurad Key Company Manufacturing Base & Headquarters Table 12. Global Lesinurad Company, Product Type & Application Table 13. Global Lesinurad Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Lesinurad by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Purity ≥ 98 % Table 18. Significant Companies of Purity ≥ 99 % Table 19. Global Lesinurad Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 20. Global Lesinurad Sales Volume by Type (2021-2026) & (t) Table 21. Global Lesinurad Sales Volume by Type (2027-2032) & (t) Table 22. Global Lesinurad Sales Volume Share by Type (2021-2026) Table 23. Global Lesinurad Sales Volume Share by Type (2027-2032) Table 24. Global Lesinurad Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Lesinurad Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Lesinurad Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Lesinurad Sales Value Share by Type (2021-2026) Table 28. Global Lesinurad Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Research Institute Table 30. Significant Companies of Pharmaceutical Table 31. Significant Companies of Others Table 32. Global Lesinurad Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 33. Global Lesinurad Sales Volume by Application (2021-2026) & (t) Table 34. Global Lesinurad Sales Volume by Application (2027-2032) & (t) Table 35. Global Lesinurad Sales Volume Share by Application (2021-2026) Table 36. Global Lesinurad Sales Volume Share by Application (2027-2032) Table 37. Global Lesinurad Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Lesinurad Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Lesinurad Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Lesinurad Sales Value Share by Application (2021-2026) Table 41. Global Lesinurad Sales Value Share by Application (2027-2032) Table 42. Global Lesinurad Sales by Region: 2021 VS 2025 VS 2032 (t) Table 43. Global Lesinurad Sales by Region (2021-2026) & (t) Table 44. Global Lesinurad Sales Market Share by Region (2021-2026) Table 45. Global Lesinurad Sales by Region (2027-2032) & (t) Table 46. Global Lesinurad Sales Market Share by Region (2027-2032) Table 47. Global Lesinurad Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Lesinurad Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Lesinurad Sales Value Share by Region (2021-2026) Table 50. Global Lesinurad Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Lesinurad Sales Value Share by Region (2027-2032) Table 52. Global Lesinurad Market Average Price (USD/t) by Region (2021-2026) Table 53. Global Lesinurad Market Average Price (USD/t) by Region (2027-2032) Table 54. Global Lesinurad Sales by Country: 2021 VS 2025 VS 2032 (t) Table 55. Global Lesinurad Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Lesinurad Sales by Country (2021-2026) & (t) Table 57. Global Lesinurad Sales Market Share by Country (2021-2026) Table 58. Global Lesinurad Sales by Country (2027-2032) & (t) Table 59. Global Lesinurad Sales Market Share by Country (2027-2032) Table 60. Global Lesinurad Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Lesinurad Sales Value Market Share by Country (2021-2026) Table 62. Global Lesinurad Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Lesinurad Sales Value Market Share by Country (2027-2032) Table 64. Ausun Pharmaceutical Company Information Table 65. Ausun Pharmaceutical Business Overview Table 66. Ausun Pharmaceutical Lesinurad Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 67. Ausun Pharmaceutical Lesinurad Product Portfolio Table 68. Ausun Pharmaceutical Recent Development Table 69. Cayman Chemical Company Information Table 70. Cayman Chemical Business Overview Table 71. Cayman Chemical Lesinurad Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 72. Cayman Chemical Lesinurad Product Portfolio Table 73. Cayman Chemical Recent Development Table 74. CHEMO Company Information Table 75. CHEMO Business Overview Table 76. CHEMO Lesinurad Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 77. CHEMO Lesinurad Product Portfolio Table 78. CHEMO Recent Development Table 79. Clearsynth Company Information Table 80. Clearsynth Business Overview Table 81. Clearsynth Lesinurad Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 82. Clearsynth Lesinurad Product Portfolio Table 83. Clearsynth Recent Development Table 84. Manus Aktteva Biopharma LLP Company Information Table 85. Manus Aktteva Biopharma LLP Business Overview Table 86. Manus Aktteva Biopharma LLP Lesinurad Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 87. Manus Aktteva Biopharma LLP Lesinurad Product Portfolio Table 88. Manus Aktteva Biopharma LLP Recent Development Table 89. MSN Labs Company Information Table 90. MSN Labs Business Overview Table 91. MSN Labs Lesinurad Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 92. MSN Labs Lesinurad Product Portfolio Table 93. MSN Labs Recent Development Table 94. Nifty Labs Company Information Table 95. Nifty Labs Business Overview Table 96. Nifty Labs Lesinurad Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 97. Nifty Labs Lesinurad Product Portfolio Table 98. Nifty Labs Recent Development Table 99. Target Mol Company Information Table 100. Target Mol Business Overview Table 101. Target Mol Lesinurad Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 102. Target Mol Lesinurad Product Portfolio Table 103. Target Mol Recent Development Table 104. UQUIFA Company Information Table 105. UQUIFA Business Overview Table 106. UQUIFA Lesinurad Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 107. UQUIFA Lesinurad Product Portfolio Table 108. UQUIFA Recent Development Table 109. Meso Chem Company Information Table 110. Meso Chem Business Overview Table 111. Meso Chem Lesinurad Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 112. Meso Chem Lesinurad Product Portfolio Table 113. Meso Chem Recent Development Table 114. Vcare Pharmatech Company Information Table 115. Vcare Pharmatech Business Overview Table 116. Vcare Pharmatech Lesinurad Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 117. Vcare Pharmatech Lesinurad Product Portfolio Table 118. Vcare Pharmatech Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Lesinurad Distributors List Table 122. Lesinurad Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Lesinurad Product Image Figure 2. Global Lesinurad Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lesinurad Sales Value (2021-2032) & (US$ Million) Figure 4. Global Lesinurad Sales (2021-2032) & (t) Figure 5. Global Lesinurad Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Lesinurad Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Purity ≥ 98 % Image Figure 10. Purity ≥ 99 % Image Figure 11. Global Lesinurad Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 12. Global Lesinurad Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Lesinurad Sales Volume Share by Type (2021-2032) Figure 14. Global Lesinurad Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Lesinurad Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Lesinurad Sales Value Share by Type (2021-2032) Figure 17. Research Institute Image Figure 18. Pharmaceutical Image Figure 19. Others Image Figure 20. Global Lesinurad Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 21. Global Lesinurad Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Lesinurad Sales Volume Share by Application (2021-2032) Figure 23. Global Lesinurad Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Lesinurad Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Lesinurad Sales Value Share by Application (2021-2032) Figure 26. Global Lesinurad Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 27. Global Lesinurad Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Lesinurad Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Lesinurad Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Lesinurad Sales Value (2021-2032) & (US$ Million) Figure 31. North America Lesinurad Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Lesinurad Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Lesinurad Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Lesinurad Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Lesinurad Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Lesinurad Sales Value (2021-2032) & (US$ Million) Figure 37. South America Lesinurad Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Lesinurad Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Lesinurad Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Lesinurad Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Lesinurad Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Lesinurad Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Lesinurad Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Lesinurad Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Lesinurad Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Lesinurad Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Lesinurad Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Lesinurad Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Lesinurad Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Lesinurad Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Lesinurad Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Lesinurad Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Lesinurad Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Lesinurad Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Lesinurad Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Lesinurad Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Lesinurad Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Lesinurad Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Lesinurad Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Lesinurad Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Lesinurad Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Lesinurad Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Lesinurad Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Lesinurad Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Lesinurad Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Lesinurad Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Lesinurad Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Lesinurad Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Lesinurad Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Lesinurad Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Lesinurad Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Lesinurad Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Lesinurad Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Lesinurad Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Lesinurad Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Lesinurad Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Lesinurad Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Lesinurad Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Lesinurad Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Lesinurad Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Lesinurad Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Lesinurad Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Lesinurad Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Lesinurad Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Lesinurad Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Lesinurad Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Lesinurad Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Lesinurad Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Lesinurad Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Lesinurad Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Lesinurad Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Lesinurad Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Lesinurad Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Lesinurad Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Lesinurad Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Lesinurad Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Lesinurad Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Lesinurad Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Lesinurad Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Lesinurad Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Lesinurad Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Lesinurad Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Lesinurad Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Lesinurad Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Lesinurad Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Lesinurad Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Lesinurad Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Lesinurad Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Lesinurad Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Lesinurad Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Lesinurad Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Lesinurad Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Lesinurad Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Lesinurad Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Lesinurad Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Lesinurad Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Lesinurad Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Lesinurad Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Lesinurad Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Lesinurad Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Lesinurad Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Lesinurad Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Lesinurad Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Lesinurad Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Lesinurad Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Purity ≥ 98 %
  • Purity ≥ 99 %
Applications
  • Research Institute
  • Pharmaceutical
  • Others
Companies covered
  • Ausun Pharmaceutical
  • Cayman Chemical
  • CHEMO
  • Clearsynth
  • Manus Aktteva Biopharma LLP
  • MSN Labs
  • Nifty Labs
  • Target Mol
  • UQUIFA
  • Meso Chem
  • Vcare Pharmatech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Lesinurad Sales Value (2021-2032)
  4. 1.2.2 Global Lesinurad Sales Volume (2021-2032)
  5. 1.2.3 Global Lesinurad Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Lesinurad Market Dynamics
  1. 2.1 Lesinurad Industry Trends
  2. 2.2 Lesinurad Industry Drivers
  3. 2.3 Lesinurad Industry Opportunities and Challenges
  4. 2.4 Lesinurad Industry Restraints
3 Lesinurad Market by Company
  1. 3.1 Global Lesinurad Company Revenue Ranking in 2025
  2. 3.2 Global Lesinurad Revenue by Company (2021-2026)
  3. 3.3 Global Lesinurad Sales Volume by Company (2021-2026)
  4. 3.4 Global Lesinurad Average Price by Company (2021-2026)
  5. 3.5 Global Lesinurad Company Ranking (2024-2026)
  6. 3.6 Global Lesinurad Company Manufacturing Base and Headquarters
  7. 3.7 Global Lesinurad Company Product Type and Application
  8. 3.8 Global Lesinurad Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Lesinurad Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Lesinurad Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Lesinurad Market by Type
  1. 4.1 Lesinurad Type Introduction
  2. 4.1.1 Purity ≥ 98 %
  3. 4.1.2 Purity ≥ 99 %
  4. 4.2 Global Lesinurad Sales Volume by Type
  5. 4.2.1 Global Lesinurad Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Lesinurad Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Lesinurad Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Lesinurad Sales Value by Type
  9. 4.3.1 Global Lesinurad Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Lesinurad Sales Value by Type (2021-2032)
  11. 4.3.3 Global Lesinurad Sales Value Share by Type (2021-2032)
5 Lesinurad Market by Application
  1. 5.1 Lesinurad Application Introduction
  2. 5.1.1 Research Institute
  3. 5.1.2 Pharmaceutical
  4. 5.1.3 Others
  5. 5.2 Global Lesinurad Sales Volume by Application
  6. 5.2.1 Global Lesinurad Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lesinurad Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Lesinurad Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Lesinurad Sales Value by Application
  10. 5.3.1 Global Lesinurad Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Lesinurad Sales Value by Application (2021-2032)
  12. 5.3.3 Global Lesinurad Sales Value Share by Application (2021-2032)
6 Lesinurad Regional Sales and Value Analysis
  1. 6.1 Global Lesinurad Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lesinurad Sales by Region (2021-2032)
  3. 6.2.1 Global Lesinurad Sales by Region: 2021-2026
  4. 6.2.2 Global Lesinurad Sales by Region (2027-2032)
  5. 6.3 Global Lesinurad Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Lesinurad Sales Value by Region (2021-2032)
  7. 6.4.1 Global Lesinurad Sales Value by Region: 2021-2026
  8. 6.4.2 Global Lesinurad Sales Value by Region (2027-2032)
  9. 6.5 Global Lesinurad Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Lesinurad Sales Value (2021-2032)
  12. 6.6.2 North America Lesinurad Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Lesinurad Sales Value (2021-2032)
  15. 6.7.2 Europe Lesinurad Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Lesinurad Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Lesinurad Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Lesinurad Sales Value (2021-2032)
  21. 6.9.2 South America Lesinurad Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Lesinurad Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Lesinurad Sales Value Share by Country, 2025 VS 2032
7 Lesinurad Country-level Sales and Value Analysis
  1. 7.1 Global Lesinurad Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Lesinurad Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Lesinurad Sales by Country (2021-2032)
  4. 7.3.1 Global Lesinurad Sales by Country (2021-2026)
  5. 7.3.2 Global Lesinurad Sales by Country (2027-2032)
  6. 7.4 Global Lesinurad Sales Value by Country (2021-2032)
  7. 7.4.1 Global Lesinurad Sales Value by Country (2021-2026)
  8. 7.4.2 Global Lesinurad Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Lesinurad Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Lesinurad Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Lesinurad Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Lesinurad Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Lesinurad Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Lesinurad Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Lesinurad Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Lesinurad Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Lesinurad Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Lesinurad Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Lesinurad Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Lesinurad Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Lesinurad Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Lesinurad Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Lesinurad Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Lesinurad Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Lesinurad Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Lesinurad Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Lesinurad Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Lesinurad Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Lesinurad Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Lesinurad Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Lesinurad Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Lesinurad Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Lesinurad Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Lesinurad Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Lesinurad Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Lesinurad Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Lesinurad Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Lesinurad Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Lesinurad Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Lesinurad Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Lesinurad Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Lesinurad Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Lesinurad Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Lesinurad Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Lesinurad Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Lesinurad Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Lesinurad Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Lesinurad Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Lesinurad Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Lesinurad Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Lesinurad Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Lesinurad Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Lesinurad Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Lesinurad Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Lesinurad Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Lesinurad Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Lesinurad Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Lesinurad Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Lesinurad Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Lesinurad Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Lesinurad Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Lesinurad Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Lesinurad Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Lesinurad Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Lesinurad Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Lesinurad Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Lesinurad Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Lesinurad Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Lesinurad Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Lesinurad Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Lesinurad Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Lesinurad Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Lesinurad Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Lesinurad Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Lesinurad Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Lesinurad Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Lesinurad Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Lesinurad Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Lesinurad Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Lesinurad Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Lesinurad Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Lesinurad Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Lesinurad Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Lesinurad Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Lesinurad Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Lesinurad Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Lesinurad Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Lesinurad Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Lesinurad Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Lesinurad Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Lesinurad Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Lesinurad Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Ausun Pharmaceutical
  2. 8.1.1 Ausun Pharmaceutical Company Information
  3. 8.1.2 Ausun Pharmaceutical Business Overview
  4. 8.1.3 Ausun Pharmaceutical Lesinurad Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Ausun Pharmaceutical Lesinurad Product Portfolio
  6. 8.1.5 Ausun Pharmaceutical Recent Developments
  7. 8.2 Cayman Chemical
  8. 8.2.1 Cayman Chemical Company Information
  9. 8.2.2 Cayman Chemical Business Overview
  10. 8.2.3 Cayman Chemical Lesinurad Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Cayman Chemical Lesinurad Product Portfolio
  12. 8.2.5 Cayman Chemical Recent Developments
  13. 8.3 CHEMO
  14. 8.3.1 CHEMO Company Information
  15. 8.3.2 CHEMO Business Overview
  16. 8.3.3 CHEMO Lesinurad Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 CHEMO Lesinurad Product Portfolio
  18. 8.3.5 CHEMO Recent Developments
  19. 8.4 Clearsynth
  20. 8.4.1 Clearsynth Company Information
  21. 8.4.2 Clearsynth Business Overview
  22. 8.4.3 Clearsynth Lesinurad Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Clearsynth Lesinurad Product Portfolio
  24. 8.4.5 Clearsynth Recent Developments
  25. 8.5 Manus Aktteva Biopharma LLP
  26. 8.5.1 Manus Aktteva Biopharma LLP Company Information
  27. 8.5.2 Manus Aktteva Biopharma LLP Business Overview
  28. 8.5.3 Manus Aktteva Biopharma LLP Lesinurad Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Manus Aktteva Biopharma LLP Lesinurad Product Portfolio
  30. 8.5.5 Manus Aktteva Biopharma LLP Recent Developments
  31. 8.6 MSN Labs
  32. 8.6.1 MSN Labs Company Information
  33. 8.6.2 MSN Labs Business Overview
  34. 8.6.3 MSN Labs Lesinurad Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 MSN Labs Lesinurad Product Portfolio
  36. 8.6.5 MSN Labs Recent Developments
  37. 8.7 Nifty Labs
  38. 8.7.1 Nifty Labs Company Information
  39. 8.7.2 Nifty Labs Business Overview
  40. 8.7.3 Nifty Labs Lesinurad Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Nifty Labs Lesinurad Product Portfolio
  42. 8.7.5 Nifty Labs Recent Developments
  43. 8.8 Target Mol
  44. 8.8.1 Target Mol Company Information
  45. 8.8.2 Target Mol Business Overview
  46. 8.8.3 Target Mol Lesinurad Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Target Mol Lesinurad Product Portfolio
  48. 8.8.5 Target Mol Recent Developments
  49. 8.9 UQUIFA
  50. 8.9.1 UQUIFA Company Information
  51. 8.9.2 UQUIFA Business Overview
  52. 8.9.3 UQUIFA Lesinurad Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 UQUIFA Lesinurad Product Portfolio
  54. 8.9.5 UQUIFA Recent Developments
  55. 8.10 Meso Chem
  56. 8.10.1 Meso Chem Company Information
  57. 8.10.2 Meso Chem Business Overview
  58. 8.10.3 Meso Chem Lesinurad Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Meso Chem Lesinurad Product Portfolio
  60. 8.10.5 Meso Chem Recent Developments
  61. 8.11 Vcare Pharmatech
  62. 8.11.1 Vcare Pharmatech Company Information
  63. 8.11.2 Vcare Pharmatech Business Overview
  64. 8.11.3 Vcare Pharmatech Lesinurad Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Vcare Pharmatech Lesinurad Product Portfolio
  66. 8.11.5 Vcare Pharmatech Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Lesinurad Value Chain Analysis
  2. 9.1.1 Lesinurad Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Lesinurad Sales Mode & Process
  6. 9.2 Lesinurad Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Lesinurad Distributors
  9. 9.2.3 Lesinurad Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst